A Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery?
Is There a Real Diaphragm-Sparing Nerve Block for Arthroscopic Shoulder Surgery?
1 other identifier
interventional
10
1 country
1
Brief Summary
This study aims at assessing the effectiveness of combined suprascapular nerve block (SSNB), infraclavicular brachial plexus block (ICB) and supraclavicular nerve block (SCNB) as surgical anesthesia for patients scheduled for arthroscopic shoulder surgery. The secondary objective is to test the hypothesis that SSNB-ICB-SCNB combination could spare the phrenic nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2017
CompletedStudy Start
First participant enrolled
June 20, 2017
CompletedFirst Posted
Study publicly available on registry
June 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2017
CompletedJuly 13, 2017
July 1, 2017
2 days
June 15, 2017
July 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
success of regional anesthesia procedure (no requirement of intraoperative general anethesia)
The primary outcome is the success rate of regional anesthesia (i.e. intraoperative conversion to general anesthesia was considered as a regional anesthesia failure). General anesthesia was defined as requirement of intraoperative invasive ventilation.
12 hours
Secondary Outcomes (1)
diaphragmatic paralysis
12 hours
Study Arms (1)
distal nerves blocks group
EXPERIMENTALThis study aims at assessing the effectiveness of combined supra scapular nerve block, infraclavicular block and supraclavicular nerve block as surgical anesthesia for patients scheduled for arthroscopic shoulder surgery. These blocks are performed for decades in routine care. The originality of this study is to analyze the combination of these different blocks for post-operative pain relief in arthroscopic shoulder surgery. This combination can be considered as an alternative to interscalene block well known to be associated with diaphragmatic paralysis. Local anesthetics used in this study are used for many years in routine care: Ropivacaine 0.375%. A single injection will be performed under ultrasounds. No continuous injection will be performed.
Interventions
* ICB: US probe will be placed just below clavicle inferior to site of needle entry. Following identification of axillary artery and cords, the needle will be advanced posterior to axillary artery. 20 cc of Ropivacaine 0.375% will then be deposited in a U-shaped distribution posterior and to each side of the axillary artery. * SSNB will be performed by locating the brachial plexus and the departure of the suprascapular nerve from the superior trunk under the inferior belly of the omohyoid muscle by sliding the transducer distally and then injecting 5 mL of ropivacaine 0.375%. * SCNB will be performed injecting 5 mL of ropivacaine 0.375% in the intermuscular plane between the sternocleidomastoid and scalene muscles using a lateral to medial in-plane technique.
Diaphragmatic excursion will be assessed under ultrasound immediately before and after regional anesthesia. This a pain free and safe procedure, that we usually perform in patients at risk of respiratory failure.
Eligibility Criteria
You may qualify if:
- Patients undergoing ambulatory arthroscopic shoulder surgery (acromioplasty and supraspinatus tendon repair) will be screened.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinique Medipole Garonne
Toulouse, 31036, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Marty Philippe
Study Record Dates
First Submitted
June 15, 2017
First Posted
June 22, 2017
Study Start
June 20, 2017
Primary Completion
June 22, 2017
Study Completion
July 10, 2017
Last Updated
July 13, 2017
Record last verified: 2017-07